Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

The treatment combination is safe and effective for some patients with this type of breast cancer.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Diphencyprone therapy for hair loss can cause vitiligo.

Pulsed electric field treatment may help the immune system fight liver tumors.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Corticosteroids effectively treated a 60-year-old man's skin condition.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Low testosterone levels may contribute to female pattern hair loss in men.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Individualized treatments may help manage Dercum's disease symptoms.